|
Volumn 98, Issue 5, 2001, Pages 745-750
|
Adjunctive intravaginal metronidazole for the prevention of postcesarean endometritis: A randomized controlled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
METRONIDAZOLE;
PLACEBO;
ADULT;
APGAR SCORE;
ARTERIAL PH;
ARTICLE;
BIRTH WEIGHT;
CESAREAN SECTION;
CHORIOAMNIONITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
ENDOMETRITIS;
FEMALE;
FEVER;
GESTATIONAL AGE;
HOSPITALIZATION;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
LENGTH OF STAY;
NEWBORN INTENSIVE CARE;
POSTOPERATIVE COMPLICATION;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
PUERPERAL INFECTION;
PUERPERIUM;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UMBILICAL ARTERY;
WOUND INFECTION;
ADMINISTRATION, INTRAVAGINAL;
ADULT;
ANTI-INFECTIVE AGENTS;
CESAREAN SECTION;
DOUBLE-BLIND METHOD;
ENDOMETRITIS;
FEMALE;
GELS;
HUMANS;
INCIDENCE;
METRONIDAZOLE;
POSTOPERATIVE COMPLICATIONS;
PREGNANCY;
PREMEDICATION;
|
EID: 0034761871
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: 10.1016/S0029-7844(01)01517-4 Document Type: Article |
Times cited : (46)
|
References (24)
|